Pelthos Therapeutics CEO to Meet Investors at Piper Sandler Symposium

Pelthos Therapeutics Inc. announced that CEO Scott Plesha will engage in one-on-one investor meetings at the Piper Sandler Spring Biopharma Symposium on April 16, 2026. This participation provides an opportunity for the company to connect with potential investors and discuss its commercial-stage biopharmaceutical portfolio, which includes ZELSUVMI for Molluscum contagiosum, Xepi for impetigo, and Xeglyze for head lice. Such engagements are crucial for investor relations and raising company visibility within the biopharma sector.